Hi, I'm Mark Horn and I manage R&D in the Life Sciences and chair international conferences. Welcome!
Mark Horn's Bio:
Mark Horn's Experience:
Global Project Management at Glaxo Smith Kline Consumer (via The FlexPro Group)2018 - Present | Greater New York City Area
• Co-lead 4 packaging innovation projects in pain relief & respiratory categories, integrating activities of Marketing, QA, R&D, Regulatory, Supply Chain, plant and co-packers • Develop and execute cross-functional plans; lead team meetings; identify, report and drive solutions for project risks; manage dependencies across projects; foster adherence to PPM governance process
Global Project & Portfolio Management at Johnson & Johnson (via The FlexPro Group)2016 - 2017 | Greater New York City Area
• R&D: CMC Project Manager for 1st small molecule ever granted accelerated development status at Janssen. Managed 6 global CMC teams. • Supply Chain: Coordinated rollout of resource management in Europe/Latam. Developed project management controls for Janssen Supply Chain sites worldwide.
Advisor to The President of EMBRAPA and Entrepreneurial Activities at MHA LLC2008 - 2015 | Brasília, Brazil
Served as advisor to the President of the Brazilian government research institute, EMBRAPA, with 10,000 employees and US $1.2 billion annual budget. Advised on organizational design in relation to technology transfer, co-led team that developed proposal to implement stage-gate project management and the designed of a new technology transfer-related business process. Did primary market research for US companies. Interviewed by Dow Jones, Al Jazeera and LA Talk Radio. Granted permanent resident visa by Brazilian National Immigration Council.
Director R&D Finance & Portfolio Management reporting to Vice President of Project Management at Wyeth Consumer Healthcare (now GSK Consumer Healthcare)1996 - 2008 | Greater New York City Area
● Director R&D Finance & Portfolio Management (2002-2008): Managed Global R&D budget in the range of US $100 to $200 million. Project management, innovation management, portfolio management, resource management, strategic planning, Rx-OTC switch. Supervised R&D Finance and Submissions groups ● Associate/Assistant Director Project Planning & Administration (1996-2001): Project management (pharmaceutical product development, pharma IT system & construction), financial management, new process design, website design, liaison to strategic licensing partners Eli Lilly & Abbott. Supervised R&D Finance group.
Mark Horn's Education:
Jodrell Laboratory (UK)Fulbright Research ScholarshipConcentration: BiochemistryActivities: Conducted research on the distribution and biological activity of polyhydroxy alkaloid sugar analogs α-Homonojirimycin and 2,5-dihydroxymethyl-3,4-dihydroxy-pyrrolidine in Urania (Lepidoptera:Uraniidae) and Omphalea (Euphorbiaceae) spp. Conference presentation: Institut de Biocenotique Experimentale des Agro-Systemes, Pau, France.
Brandeis UniversityBachelor's DegreeConcentration: BiologyActivities: Study Abroad: Bedford College, University of London, UK.
Seton Hall UniversityMaster's DegreeConcentration: Corporate and Public Communication: MBA TrackActivities: Completed Master's thesis on Web Design.
University of California IrvineGraduate StudyConcentration: BiologyActivities: Completed coursework towards PhD.
Mark Horn's Interests & Activities:
Chair or Presenter at 25 International Conferences in US, Europe & Latin America (selected examples): ● Chair: Project & Portfolio Mgmt. for Pharma & Biotech West, San Francisco, Jul 24-25, 2019 (Fleming) ● Chair: Digital Innovation in Healthcare, Bratislava, Apr 3-5, 2019 (Why Summits) ● Chair: AgriYield: Central/Eastern European Yield/Optimisation Summit, Prague, Nov 25-26, 2010 (FCBI) ● Keynote Speaker: Relationship Building, PPM Conference, Bratislava, Apr 5, 2019 (Why Summits) ● Presenter/Panelist: Doing Business in Brazil, Wellesley, Sep 23, 2013 (IERG/Brazil Today) ● Presenter: Open Innovation, São Paulo, Feb 28-29, 2012 (Marcus-Evans)